Table 3.
NTM species distribution and clinical phenotypes.
| Species | n (%) | Neoplastic/polypoid morphology | Bone destruction | Improved/cured |
|---|---|---|---|---|
| M. colombiense | 7(24.1) | 7 (100) | 6 (85.7) | 6 (85.7) |
| M. avium | 6(20.7) | 5 (83.3) | 1(16.7) | 6(100) |
| M. intracellulare | 5(17.2) | 2 (40.0) | 2 (40.0) | 5 (100) |
| M. avium complex | 2 (6.9) | 2(100) | 2(100) | 2(100) |
| M. abscessus | 2(6.9) | 2 (100) | 1 (50.0) | 2 (100) |
| M. kansasii | 1 (3.4) | 0 (0) | 0 (0) | 1 (100) |
| M. chelonae | 1 (3.4) | 0 (0) | 0 (0) | 1 (100) |
| M. florentinum | 1 (3.4) | 1 (100) | 0 (0) | 1 (100) |
| Not specified | 6 (20.7) | 3 (50.0) | 2 (33.3) | 4 (66.7) |
| Total | 29(100) | 25 (86.2) | 11(37.9) | 24 (82.8) |
Data are presented as n (%). Comparisons across species were performed using Fisher’s exact test.